Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Sep 18;2(2):fcaa147. doi: 10.1093/braincomms/fcaa147

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Dose-dependent effects of rTMS on clinical outcome measures. (A) Association between stimulation intensity and improvement in dyskinesia severity. (B) Association between stimulation intensity and prolongation of time between levodopa intake and the onset of dyskinesia. (C) Group mean rTMS-induced electrical field. (D) The rTMS-induced delay in dyskinesia onset correlated positively with the induced electrical field strength in preSMA. (E) Correlation between rTMS-induced delay in dyskinesia onset and mean induced electrical field strength in a sphere (r = 20 mm) centred at the stimulation target (MNI x, y, z = 4, 8, 58). Shaded areas around linear fits represent the 95% confidence interval.